Dr. Gallegos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7500 Mercy Rd
Ste 618
Omaha, NE 68124Phone+1 515-322-2769Fax+1 888-592-3848
Summary
- Robert Gallegos, the Chief of Cardiac Surgery and Associate Professor at Creighton University School of Medicine, CHI Bergan Mercy, specializes in adult cardiovascular surgery(MIS, structural). He holds a BS in Bioengineering, PhD Experimental and is currently completing an MBA. He has extensive experience with clinical and preclinical trials. He also has extensive experience with patent law.
Education & Training
- University of IowaMBA, Business, 2023 - 2025
- Brigham and Women's Hospital/Children's HospitalFellowship, Thoracic Surgery, 2006 - 2008
- University of MinnesotaResidency, Surgery, 1998 - 2006
- University of California San Diego School of MedicineClass of 1998
Certifications & Licensure
- NE State Medical License 2023 - Present
- MA State Medical License 2008 - 2026
- MD State Medical License 2022 - 2026
- AZ State Medical License 2022 - 2025
- IA State Medical License 2017 - 2025
- IN State Medical License 2011 - 2025
- KY State Medical License 2011 - 2025
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- American College of Cardiology Fellow
- American College of SurgeonsFellow
- Join now to see all
Awards, Honors, & Recognition
- Lillehei-Bakken Award Lillehei Society
- Coleman Connelly Award for outstanding surgical teaching University of Minnesota
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation Start of enrollment: 2005 Mar 01
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk Start of enrollment: 2011 Mar 01
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPerfusion preservation of the donor heart: Basic science to pre-clinicalAndrew L. Rivard, Robert P. Gallegos, Irene M. Ogden, Richard W. Bianco
The Journal of Extra-Corporeal Technology. 2009-09-01 - 47 citationsThe current state of in-vivo pre-clinical animal models for heart valve evaluation.Robert P. Gallegos, Pavel J Nockel, Andrew L. Rivard, Richard W. Bianco
The Journal of Heart Valve Disease. 2005-05-01 - 87 citationsFunctionally Competent Cardiac Stem Cells Can Be Isolated From Endomyocardial Biopsies of Patients With Advanced CardiomyopathiesDomenico D'Amario, Claudia Fiorini, Patricia Campbell, Polina Goichberg, Fumihiro Sanada
Circulation Research. 2011-04-01
Journal Articles
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsGallegos RP as part of Partner II investigators, NEJM, 4/28/2016
- Prevention of HeartMate II pump thrombosis-recommendations and preliminary observations from the PREVENT studyS itaramesh Emani, Mary Keebler, John M Ransom, Ahmet Kilic, Gregory Egnacyzk, Robert Gallegos, Paul Mather, John Stulak, Igor Gregoric, Jason Katz, Charles T Klodell,..., Circulation, 11/10/2015
Authored Content
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsApril 2016
Professional Memberships
- Past President Central Iowa
- Fellow
External Links
- Linked Inhttp://www.linkedin.com/in/rob-gallegosMDPhD85381665
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: